Cargando…
Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for l-Type Amino Acid Transporter 1-Utilizing Prodrugs
[Image: see text] Membrane transporters are the key determinants of the homeostasis of endogenous compounds in the cells and their exposure to drugs. However, the substrate specificities of distinct transporters can overlap. In the present study, the interactions of l-type amino acid transporter 1 (...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906736/ https://www.ncbi.nlm.nih.gov/pubmed/36688491 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00948 |
_version_ | 1784884037319393280 |
---|---|
author | Huttunen, Johanna Kronenberger, Thales Montaser, Ahmed B. Králová, Adéla Terasaki, Tetsuya Poso, Antti Huttunen, Kristiina M. |
author_facet | Huttunen, Johanna Kronenberger, Thales Montaser, Ahmed B. Králová, Adéla Terasaki, Tetsuya Poso, Antti Huttunen, Kristiina M. |
author_sort | Huttunen, Johanna |
collection | PubMed |
description | [Image: see text] Membrane transporters are the key determinants of the homeostasis of endogenous compounds in the cells and their exposure to drugs. However, the substrate specificities of distinct transporters can overlap. In the present study, the interactions of l-type amino acid transporter 1 (LAT1)-utilizing prodrugs with sodium-coupled neutral amino acid transporter 2 (SNAT2) were explored. The results showed that the cellular uptake of LAT1-utilizing prodrugs into a human breast cancer cell line, MCF-7 cells, was mediated via SNATs as the uptake was increased at higher pH (8.5), decreased in the absence of sodium, and inhibited in the presence of unselective SNAT-inhibitor, (α-(methylamino)isobutyric acid, MeAIB). Moreover, docking the compounds to a SNAT2 homology model (inward-open conformation) and further molecular dynamics simulations and the subsequent trajectory and principal component analyses confirmed the chemical features supporting the interactions of the studied compounds with SNAT2, which was found to be the main SNAT expressed in MCF-7 cells. |
format | Online Article Text |
id | pubmed-9906736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-99067362023-02-08 Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for l-Type Amino Acid Transporter 1-Utilizing Prodrugs Huttunen, Johanna Kronenberger, Thales Montaser, Ahmed B. Králová, Adéla Terasaki, Tetsuya Poso, Antti Huttunen, Kristiina M. Mol Pharm [Image: see text] Membrane transporters are the key determinants of the homeostasis of endogenous compounds in the cells and their exposure to drugs. However, the substrate specificities of distinct transporters can overlap. In the present study, the interactions of l-type amino acid transporter 1 (LAT1)-utilizing prodrugs with sodium-coupled neutral amino acid transporter 2 (SNAT2) were explored. The results showed that the cellular uptake of LAT1-utilizing prodrugs into a human breast cancer cell line, MCF-7 cells, was mediated via SNATs as the uptake was increased at higher pH (8.5), decreased in the absence of sodium, and inhibited in the presence of unselective SNAT-inhibitor, (α-(methylamino)isobutyric acid, MeAIB). Moreover, docking the compounds to a SNAT2 homology model (inward-open conformation) and further molecular dynamics simulations and the subsequent trajectory and principal component analyses confirmed the chemical features supporting the interactions of the studied compounds with SNAT2, which was found to be the main SNAT expressed in MCF-7 cells. American Chemical Society 2023-01-23 /pmc/articles/PMC9906736/ /pubmed/36688491 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00948 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Huttunen, Johanna Kronenberger, Thales Montaser, Ahmed B. Králová, Adéla Terasaki, Tetsuya Poso, Antti Huttunen, Kristiina M. Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for l-Type Amino Acid Transporter 1-Utilizing Prodrugs |
title | Sodium-Dependent Neutral Amino Acid Transporter 2
Can Serve as a Tertiary Carrier for l-Type Amino Acid
Transporter 1-Utilizing Prodrugs |
title_full | Sodium-Dependent Neutral Amino Acid Transporter 2
Can Serve as a Tertiary Carrier for l-Type Amino Acid
Transporter 1-Utilizing Prodrugs |
title_fullStr | Sodium-Dependent Neutral Amino Acid Transporter 2
Can Serve as a Tertiary Carrier for l-Type Amino Acid
Transporter 1-Utilizing Prodrugs |
title_full_unstemmed | Sodium-Dependent Neutral Amino Acid Transporter 2
Can Serve as a Tertiary Carrier for l-Type Amino Acid
Transporter 1-Utilizing Prodrugs |
title_short | Sodium-Dependent Neutral Amino Acid Transporter 2
Can Serve as a Tertiary Carrier for l-Type Amino Acid
Transporter 1-Utilizing Prodrugs |
title_sort | sodium-dependent neutral amino acid transporter 2
can serve as a tertiary carrier for l-type amino acid
transporter 1-utilizing prodrugs |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906736/ https://www.ncbi.nlm.nih.gov/pubmed/36688491 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00948 |
work_keys_str_mv | AT huttunenjohanna sodiumdependentneutralaminoacidtransporter2canserveasatertiarycarrierforltypeaminoacidtransporter1utilizingprodrugs AT kronenbergerthales sodiumdependentneutralaminoacidtransporter2canserveasatertiarycarrierforltypeaminoacidtransporter1utilizingprodrugs AT montaserahmedb sodiumdependentneutralaminoacidtransporter2canserveasatertiarycarrierforltypeaminoacidtransporter1utilizingprodrugs AT kralovaadela sodiumdependentneutralaminoacidtransporter2canserveasatertiarycarrierforltypeaminoacidtransporter1utilizingprodrugs AT terasakitetsuya sodiumdependentneutralaminoacidtransporter2canserveasatertiarycarrierforltypeaminoacidtransporter1utilizingprodrugs AT posoantti sodiumdependentneutralaminoacidtransporter2canserveasatertiarycarrierforltypeaminoacidtransporter1utilizingprodrugs AT huttunenkristiinam sodiumdependentneutralaminoacidtransporter2canserveasatertiarycarrierforltypeaminoacidtransporter1utilizingprodrugs |